The antimycobacterial activity of a new series of 2-acetylpyridine thiosemicarbazones was determined in vitro using Mycobacterium smegmatis ATCC 607. The resulting log minimal inhibitory concentration (pmol l-l) values were plotted against the partition coefficient (log P) values for each compound, and fell on a parabolic distribution curve having a log Popt of 3.0. Compounds having partition coefficients outside the range 2.0 to 4.0 were inactive against M . smegmatis. When similar assays were carried out using M . tuberculosis, M . kansasii, M. marinum, M . simiae, M. avium and M . intracellulare, a similar series of parabolic activity curves were obtained having log Popt values around 4.0. The significance of this shift in the log Popt value obtained using the slow-growing pathogenic mycobacteria compared to that observed with the rapid-growing M . smegmatis is discussed in relation to the structures of the variable substituents of these new 2-acetylpyridine thiosemicarbazone compounds.
I N T R O D U C T I O N
Thiosemicarbazones exhibit significant antimycobacterial activity against both tubercle and leprosy bacilli in vivo (Behnisch et al., 1950; Domagk, 1950; Lowe, 1954) . The most widely studied drug in this class of compound is thiacetazone (p-acetamidobenzaldehyde thiosemicarbazone). However, this drug has not been widely used in recent studies, partly because of its predominantly bacteriostatic action in vivo and partly because of the rapid emergence of thiacetazone-resistant strains during therapy (Lowe, 1954) .
Recently, a number of newly synthesized 2-acetylpyridine thiosemicarbazones have been reported to possess substantial antimalarial (Klayman et al., 1979 a, b) and antimicrobial (Dobek et al., 1980) activity, including activity against several organisms having clinical significance for man. No information was available regarding the potential antituberculous activity of these compounds, however. The present study examines the activity of a number of these compounds in vitro against various mycobacteria known to be pathogenic for man (Wolinsky, 1979) .
M E T H O D S
Organisms. Mycobacterium tuberculosis H,,Rv (TMC 102), M. kansasii (TMC 1204) , M. marinum (TMC 1219), M . simiae (TMC 1226) , M. avium (TMC 706) and M. intracellulare (TMC 1406) were obtained from the Trudeau Mycobacterial Culture Collection (TMC), Saranac Lake, N.Y., U.S.A.; M. smegmatis (ATCC 607) was obtained from the American Type Culture Collection, and maintained on Lowenstein-Jensen slants (Morrison, 197 
2-Acetylpyridine thiosemicarbazones.
The compounds shown in Figs 1 and 2 were synthesized by procedures reported elsewhere (Klayman et al., 1979 a b) . The thiosemicarbazones were dissolved in dimethyl sulphoxide (DMSO) at a concentration of 10 mg ml-' before being diluted aseptically in sterile culture medium to give a concentration range of 0.075 to 100 pg ml-'. A final concentration of 0.5 % (v/v) DMSO was present in all of the tubes, including the controls.
Minimal inhibitory concentration (m.i.c.) determinations. (i) M . smegmatis A TCC 607. The determinations were carried out in screw-capped tubes containing 5 ml of Kirchner medium, with and without the test compound. All tubes were inoculated with lo5 viable colony-forming units (c.f.u.) of M . smegmatis and rotated in tissue culture roller drums at 37 OC for 72 h. The culture medium contained 0.5% (v/v) Tween 80, without added albumin. The high concentration of detergent did not inhibit growth of M . smegmatis but produced the evenly dispersed growth essential for reproducible turbidimetric determinations. The increase in turbidity was measured at 650 nm. The end-point was taken as the lowest thiosemicarbazone concentration resulting in 95 % inhibition of growth, compared with the control turbidity measurements. (ii) M . tuberculosis and other slow-growing mycobacteria. The tests were carried out in 5 ml of Middlebrook 7H9 liquid medium containing 0.05% (v/v) Tween 80, and enriched with 10 % (v/v) ADC supplement (Difco). Thiosemicarbazone concentrations were varied in two-fold steps from 40 to 0.075 pg ml-' of 7H9 broth containing 0.5% (v/v) DMSO. The tubes were inoculated with approximately lo5 viable c.f.u. of mycobacteria and incubated at 37 "C. The amount of growth inhibition was assessed after 2 weeks incubation. The m.i.c. value was taken as the lowest concentration of a compound to cause a 95 % reduction in turbidity relative to that observed in the controls.
Partition coeficient (log P) calculations. The octanol/water partition coefficients (log P ) were calculated from the additive Hansch log P and 7~ values (Hansch & Leo, 1979) for each thiosemicarbazone. The following values were used: pyridine = +0.65, methyl = +0.56 and thiosemicarbazone = -0.27. Other values for the alkyl, cycloalkyl and azacycloalkyl portions of the variable R substituents (see Fig. I ) were derived from the tables provided by Leo et al. ( 19 7 1) .
Statistical analysis. The log,,m.i.c. ( p o l 1-l) values were subjected to polynomial regression analysis and found to conform to a parabolic distribution having the general form y = a + bx + cxz using the method of least squares fit (Zar, 1974) .
R E S U L T S
Antimycobacterial activity against M. smegmatis 607 Since M . smegmatis 607 had been used earlier to pre-screen a number of compounds for antileprosy activity (Morrison, 197 l) , a preliminary study was carried out using 18 2-acetylpyridine thiosemicarbazones tested against this rapid grower ( Table 1 ). The most active compounds (0, 3, 5, 14 and 33), all had m.i.c. values of less than 2.5 pg ml-I indicating that the N4 substitution of a azetidino, ethyl, allyl, benzyl or pyrrolidino group ( Fig. 1 ) resulted in strong growth inhibition of this organism. A second group of compounds (25, 3 1, 37, 45, 47 and 50) were somewhat less active (m.i.c. 2.5 to 5 pg ml-l) suggesting that substitution in the N4 position with a cyclohexyl, methyl and cyclohexyl, piperidino, azacycloheptyl or azabicyclononane ring also resulted in increased antimycobacterial activity. The remaining compounds (1, 2, 26, 29, 43, 46 and 49) were essentially inactive against this organism (m.i.c. 10 to 100 pg ml-l). Comparison of this m.i.c. data in terms of the structural formulae shown in Fig. 1 did not demonstrate any obvious sequential pattern between the structure of the N4 substituent and an increasing level of antimycobacterial activity. However, at least part of this variability could have been due to the wide variation in the type of N4 substituents tested, and so it was decided to examine a single homologous series of compounds having an increasing alkyl chain length in terms of their activity against M . srnegmatis 607 in vitro. A Hansch analysis (Tute, 1971) was then carried out on this straight-chain series of N4-aliphatic substituted 2-acetylpyridine thiosemicarbazones (Fig. 2) . Maximum antimycobacterial activity occurred with compounds bearing the C,-C, substituents (compounds 3, 4, 4a and 7), with a sharp decrease in antimicrobial activity (m.i.c. >lo0 pg ml-l) as the carbon-chain length increased beyond this point. When a regression analysis was carried out on the plots of the log m.i.c. values in terms of the corresponding partition coefficients (log P) for each compound, a parabolic curve was obtained having a log Popt value of 2.5. The regression coefficient for this curve of best fit was highly significant (r2 = 0-92, n = 8 , p < 0.01).
Hydrophobicity and antimycobacterial activity of the 2-acetylpyridine thiosemicarbazones
The m.i.c. values determined against M. smegmatis shown in Table 1 for the 18 test thiosemicarbazones were subjected to a Hansch analysis. The resulting distribution curve for the log m.i.c. values in terms of the partition coefficients (log P) for each compound again conformed to a parabolic curve of best fit having a log Po,,, of 3 -0 (Fig. 3) .
Antibacterial activity against M. tuberculosis and other slow-growing mycobacteria
With the above data as a basis for comparison, similar studies were carried out with the 18 test thiosemicarbazones using an extended range of mycobacterial species. The resulting Dobek et al. (1980) ; structures as shown in Fig. 1 . Partition coefficient (log P) When a Hansch analysis was carried out on the log m.i.c. data obtained using the slow-growing mycobacteria, a series of parabolic regression curves was obtained (Fig. 4) in which the log POqt values all fell in the region of 4.0. The regression coefficients for these six curves were all significant (r2 = 0.71 to 0.90). The curves for M. marinum and M. simiae were displaced upwards due to the resistance shown by both organisms to most of the thiosemicarbazones. However, it should be noted that the log Popt values for both these organisms were still about 4 -0 (Fig. 4) .
D I S C U S S I O N
The 2-acetylpyridine thiosemicarbazones are a new class of hydrophobic compounds expressing a wide spectrum of antibacterial and antiprotozoal activity in vitro (Klayman et al., 1979a; Dobek et al., 1980; Brown et al., 1981) . The greatest antimicrobial activity seemed to be expressed against Neisseria gonorrhoea and N. meningitidis, but some inhibition was also observed using Staphylococcus aureus and a group D enterococcus (Dobek et al., 1980) . At present, little is known about the mode of action of these compounds. Brown et al. ( 198 1) reported that relatively high concentrations ( 18 IM) of 2-acetylpyridine thiosemicarbazone azacycloheptane (compound 45) resulted in an early inhibition of RNA synthesis by Escherichia coli suspensions incubated in the presence of tritiated uracil. Unfortunately, E. coli is relatively resistant to this class of compound in vitro (Dobek et al., 1980) and it is not known whether mycobacteria exhibit a similar type of inhibition. The present study indicates that antimicrobial activity extends to a number of mycobacterial species, with maximum antimycobacterial activity occurring for compounds having partition coefficients (log P values) between 3.0 and 4-0. Comparison of the regression curves shown in Figs 3 and 4 indicates that compounds having log P values of less than 2.0 or more than 4.5 were inactive against both types of mycobacteria, suggesting that the activity of these compounds depends upon their possessing an optimum hydrophobicity, which in turn controls their rate of entry into the bacterial cell (Tute, 1971) . A second possibility is that the hydrophobicity of the compound affects its ability to bind to a specific receptor at the site of drug action within the cell (Hansch & Leo, 1979; Leo et al., 1971) . At present, we have no The five compounds active against M . smegmatis had an average log P of 2.5, while the four compounds active against M . tuberculosis had an average log P of 4.2.
indication as to the relative contributions by these two processes to the overall antimycobacterial activity of these compounds.
The shift in log Popt values for the active thiosemicarbazones [log m.i.c. (ymol 1-') < 11 against M . smegmatis 607, compared with M . tuberculosis (Fig. 5) , was largely due to the high antibacterial activity expressed by compounds 0, 3, 5 , 14 and 33 (average log P of 2.5) against the rapid grower while the same compounds were virtually inactive when tested against M . tuberculosis. Conversely, compounds active against the slow growers (compounds 31, 37,45 and 50) still showed substantial, though reduced, activity against the rapid growers and the average log P value for these compounds was 4.2. Comparison of the structures of the variable R substituents in these two groups of compounds indicates that the first group (0, 3, 5 , 14 and 33) were for the most part secondary amines with an average molecular weight of 234 5.8 (mean f s.E.). On the other hand, compounds with activity against both types of mycobacteria had a tertiary N4-amine structure and an average molecular weight of 290 & 5.3. This difference was highly significant ( p < 0.001). Such a shift (representing an addition of three or four methylene residues to the variable R substituent) should be assessed in terms of the potential chemotherapeutic activity of these new thiosemicarbazone compounds against various human pathogens, both in vitro and in vivo. Potential antileprosy activity for several of these compounds was observed in terms of inhibition of growth by M . leprae in the mouse footpad (Morrison & Collins, 1981) . The log Popt value for the active compounds in vivo was around 2.0 which represents a significant shift in the partition coefficient from the present data obtained with M . smegmatis 607 (Fig. 3) . This difference was ascribed to tissue diffusional factors affecting drug activity in vivo Tute, 1971) . Similar tissue diffusional factors may also affect the rate at which these thiosemicarbazones enter infected lung tissue and so it is important that in vivo tests of the most active of the compounds reported in Table 2 be repeated in mice infected aerogenically with virulent M . tubercdosis and other m ycobacterial pathogens.
The direct correlation observed between the optimum hydrophobicity of compounds 3 1, 37, 45, 47 and 50 and the level of antimycobacterial activity expressed against both rapid and slow growers in vitro suggests that active transport mechanisms (Leo et al., 1971; Tute, 1971 ) are unlikely to be involved in the entry of these compounds into the microbial cell. It seems probable that most of the active compounds enter the cell by a 'random-walk' mechanism (Fujita & Hansch, 1967) mediated by some type of free-energy change as the compounds partition between the aqueous phase and the membrane lipids. It is known that the membrane lipids of the fast-growing mycobacteria differ both qualitatively and quantitatively from those of slow-growing species (Goren, 1972) . Such differences could well be responsible for the observed structure-activity shifts observed with the different thiosemicarbazones tested in vitro against the two types of mycobacteria (Fig. 5) . As a result, both the tissue diffusional factor and the partitioning characteristic of the individual 2-acetylpyridine thiosemicarbazone should be taken into account in any future attempts to investigate the potential antituberculous activity of these compounds, based on their in vitro activity. Such factors are also likely to be important (Martin, 1978) in the design of new members of this thiosemicarbazone series with enhanced chemotherapeutic potential against these organisms.
